Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
Abstract
The present invention provides a method of increasing neural stem cell numbers or neurogenesis by using a pheromone, a luteinizing hormone (LH) and/or a human chorionic gonadotrophin (hCG). The method can be practiced in vivo to obtain more neural stem cells in situ, which can in turn produce more neurons or glial cells to compensate for lost or dysfunctional neural cells. The method can also be practiced in vitro to produce a large number of neural stem cells in culture. The cultured stem cells can be used, for example, for transplantation treatment of patients or animals suffering from or suspected of having neurodegenerative diseases or conditions.
Claims
exact text as granted — not AI-modified1. A method of enhancing neurogenesis in a mammal in need thereof, comprising administering an effective amount of a luteinizing hormone (LH) and erythropoietin (EPO) or a human chorionic gonadotrophin (hCG) and EPO to the mammal, wherein neurogenesis is enhanced in the mammal.
2. The method of claim 1 wherein the mammal is an adult.
3. The method of claim 1 wherein the neurogenesis occurs in the subventricular zone.
4. The method of claim 1 wherein the neurogenesis occurs in the hippocampus.
5. The method of claim 1 wherein the LH or hCG is administered systemically.
6. The method of claim 1 wherein the LH or hCG is administered to the brain of the mammal.
7. The method of claim 1 wherein the mammal has a neurodegenerative disease or condition.
8. The method of claim 7 , wherein the neurodegenerative disease is a CNS injury.
9. The method of claim 7 , wherein the neurodegenerative disease is a stroke.
10. The method of claim 1 , wherein neurogenesis is indicated by the presence of doublecortin-positive or NeuN-positive cells.
11. A method of increasing neural stem cell proliferation in vitro, comprising contacting at least one neural stem cell with an effective amount of a luteinizing hormone (LH) and erythropoietin (EPO) or a human chorionic gonadotrophin (hCG) and EPO.
12. The method of claim 11 wherein the neural stem cell is derived from an adult mammal.
13. The method of claim 11 wherein the neural stem cell is derived from the subventricular zone of a mammal.
14. The method of claim 11 wherein the neural stem cell is derived from the hippocampus of a mammal.
15. A method of enhancing neurogenesis in vitro, comprising contacting at least one neural stem cell with an effective amount of a luteinizing hormone (LH) and erythropoietin (EPO) or a human chorionic gonadotrophin (hCG) and EPO.
16. The method of claim 15 wherein the neural stem cell is derived from an adult mammal.
17. The method of claim 15 wherein the neural stem cell is derived from the subventricular zone of a mammal.
18. The method of claim 15 wherein the neural stem cell is derived from the hippocampus of a mammal.Join the waitlist — get patent alerts
Track US7846898B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.